Papua New Guinea

Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

Postpartum 8-aminoquinoline Breast Milk Study

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Emergency Department Triage in a Resource Constrained Setting: Application of the World Health Organization Triage Scale in Regional Papua New Guinea

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG

East New Britain Province Monitoring & Evaluation

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

Estimating Usual Iodine Intake From Spot Urinary Iodine Concentrations

Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

An Accessible Low-cost Plant Treatment for Cutaneous Ulcers